TotalSeq™-C0395 anti-human B7-H4 Antibody, B7-H4, MIH43,BioLegend,358116

Additional reported applications (for the relevant formats) includes immunofluorescence2.

Host

Mouse

Reactivity

Human

Application

PG -Quality tested

Platform ID

BAB692658153

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-C0395 anti-human B7-H4 Antibody, B7-H4, MIH43
Cat. No.358116
HostMouse
RRIDAB_2800986 (BioLegend Cat. No. 358116)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationPG -Quality tested
ClonalityMonoclonal
Clone NumberMIH43
Concentration0.5 mg/ml
TargetB7-H4
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-C oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

B7-H4, also known as VTCN1, is a type I transmembrane protein and member of the B7 family. Its extracellular region consists of one IgV-like and one IgC-like domain. B7-H4 expression has been reported on activated T cells, B cells, monocytes, and dendritic cells. On T cells, B7-H4 inhibits proliferation, cytokine secretion, and cytotoxicity. B7-H4 is also expressed by different carcinomas including renal, gastric, breast, ovarian and melanoma. Its expression is associated with a poor prognosis.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.